healthNewsغير مصنف

Abbott, AbbVie settle U.S. case over TriCor marketing for $25 million

Abbott Laboratories and AbbVie Inc will pay $25 million to resolve allegations that Abbott paid kickbacks to doctors in exchange for them prescribing the cholesterol drug TriCor and promoted the medication for unapproved purposes.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى